Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells.
Washington D.C. [USA], Apr 1 (ANI): Scientists have found that rare and aggressive neuroendocrine tumours shrink through a combination of two common immunotherapy drugs.